Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)
Viatris(VTRS) Prnewswire·2024-10-09 18:59Viatris(VTRS) Prnewswire·2024-10-09 18:59
R1Viatris(VTRS) Prnewswire·2024-10-09 18:59